Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD
Author(s): Martin David Harp Key Takeaways Alcon’s acquisition of LumiThera includes a PBM device for early and intermediate dry AMD, enhancing its non-invasive treatment portfolio. LumiThera’s PBM device demonstrated significant…